The coronavirus disease 2019 (COVID-19) drug pipeline is not growing at quite the same speed as the pandemic. But its rate of expansion is nevertheless cause for pause. In the months since COVID-19 has spread, researchers have launched more than 180 clinical trials of everything from repurposed antivirals and immuno modulators to unproven cell therapies and vitamin C. A further 150 trials are preparing to recruit patients.
Links:
[1] http://admin.indiaenvironmentportal.org.in/reports-documents/flooded-torrent-covid-19-drug-pipeline
[2] http://www.indiaenvironmentportal.org.in/files/file/Flooded-by-the-torrent-the COVID-19drug-pipeline.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/publisher/lancet-commissions
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/global
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/coronavirus
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/respiratory-diseases
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs